Association for Creatine Deficiencies

Mission Statement

ACD™ mission is to provide patient, family, and public education. To advocate for early intervention through newborn screening, to promote and fund medical research for treatments and cures for Cerebral Creatine Deficiency Syndromes (CCDS). Our vision is to have effective treatments and newborn screening for all three CCDS while providing community support. In this future, the rare disease diagnostic odyssey changes from seven years to seven days to treatment, and all CCDS patients achieve their potential.